Cancer Research UK is investing £190 million across 13 Cancer Research UK Centres over the next five years.
Additionally, Cancer Research UK and the Departments of Health (National Institute for Health Research (England), Chief Scientist Office (Scotland), Public Health Agency (Northern Ireland) and the Health and Care Research Wales )are investing £36 million over five years into 18 Experimental Cancer Medicine Centres (ECMCs) for adult patients and also a network of Centres for children.
The paediatric ECMC network focuses on rare children’s cancers and early phase trials that bring new treatments to children. The network is also advancing research in immunotherapy, precision medicine, and collecting crucial samples for research into children’s cancers in the future.
The huge investment will draw together world class research and medical expertise to accelerate advances in research and support clinical trials essential to getting lifesaving treatments to patients.